Brief: Caplin Point Labs Gets USFDA Approval For Argatroban Injection
22/01/2021 11:01
Jan 22 (Reuters) - Caplin Point Laboratories Ltd CAPL.NS :
* GETS USFDA APPROVAL FOR ARGATROBAN INJECTION
Source text for Eikon: ID:nBSE36DqWk
Further company coverage: CAPL.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Caplin Point Laboratories
See all newsBrief: Caplin Point Laboratories Says US FDA Completes Unannounced Inspection Of Caplin Steriles Gummidipoondi Facility
Brief: Caplin Point Laboratories March-Quarter Consol Net Profit 1.7 Bln Rupees
Brief: Caplin Point Laboratories Unit Receives Final USFDA Approval For ANDA Potassium Phosphates Injection
Brief: Caplin Point Laboratories Says Unit Receives USFDA Approval For Sodium Phosphates Injection
Brief: Caplin Point Laboratories Dec-Quarter Consol Net Profit 1.64 Billion Rupees